Related Experiment Video
Updated: Mar 14, 2026
05:54
Real-Time Dynamic Navigation System for the Precise Quad-Zygomatic Implant Placement in a Patient with a Severely Atrophic Maxilla
Published on: October 18, 2021
2.4K
Surgical complications in zygomatic implants: A systematic review
P Molinero-Mourelle1, L Baca-Gonzalez, B Gao
1Departamento de Estomatología III, Medicina y Cirugía Bucofacial, Facultad de Odontología, Universidad Complutense de Madrid, Plaza de Ramón y Cajal, 3, 28040 Madrid, jlopezquiles@gmail.com.
Medicina Oral, Patologia Oral Y Cirugia Bucal
|October 4, 2016
Summary
Zygomatic implants offer an alternative for severe maxillary bone atrophy but can cause complications. Sinusitis and osseointegration failure are the most frequent surgical issues, impacting patient rehabilitation.
Area of Science:
- Oral and Maxillofacial Surgery
- Dental Implantology
- Reconstructive Dentistry
Background:
- Zygomatic implants are a therapeutic option for severe maxillary bone atrophy.
- These implants are associated with potential surgical complications.
- Understanding these complications is crucial for successful patient rehabilitation.
Purpose of the Study:
- To review and identify the most common surgical complications linked to zygomatic implant use.
- To analyze the frequency of these complications in patients with severe maxillary bone atrophy.
Main Methods:
- Conducted a comprehensive electronic and manual literature search.
- Included clinical trials and case series with 6-12 month follow-up.
- Selected studies reporting at least two types of complications.
Main Results:
- Analyzed 14 studies from an initial pool of 455.
- Identified sinusitis (3.9%) and osseointegration failure (2.44%) as the most frequent complications.
- Highlighted the incidence rates of these specific surgical issues.
Conclusions:
- Sinusitis and osseointegration failure are the primary surgical complications of zygomatic implants.
- A standardized system for collecting complication data is necessary.
- Further research should focus on mitigating these common adverse events.
